ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 106 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,453,000 | -28.9% | 140,000 | 0.0% | 0.12% | -36.1% |
| Q4 2017 | $3,452,000 | -4.5% | 140,000 | 0.0% | 0.18% | -12.2% |
| Q3 2017 | $3,613,000 | -4.8% | 140,000 | 0.0% | 0.20% | -13.1% |
| Q2 2017 | $3,797,000 | -9.1% | 140,000 | 0.0% | 0.24% | -14.5% |
| Q1 2017 | $4,175,000 | -30.1% | 140,000 | -36.4% | 0.28% | -28.9% |
| Q4 2016 | $5,971,000 | +66.6% | 220,000 | +57.1% | 0.39% | +77.2% |
| Q3 2016 | $3,585,000 | – | 140,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |